Clinical Trials on Percutaneous Tracheostomy in New Zealand

Total 28 results

Medeon Biodesign, Inc.

Completed

Clinical Study of the Medeon Biodesign XPro™

Percutaneous Closure of Arteriotomy in Common Femoral Artery

Taiwan, New Zealand, Australia
Icahn School of Medicine at Mount Sinai

Recruiting

Investigation of a 3 oz Water Protocol on Patients With Tracheostomies

Tracheostomy

United States
Yale University

Completed

A Comparison of the Blom Low Profile Voice Inner Cannula and the Passy-Muir One-Way Tracheotomy Tube Speaking Valve on Voice Production, Speech Intelligibility, and Biomechanical Swallowing Behavior

Mechanical Complication of Tracheostomy

United States
Fu Jen Catholic University

Terminated

The Application and Analysis of Diaphragm Electrical Impulse in Adult Patients With Spontaneous Breathing Trial

Tracheostomy

Taiwan
Vivasure Medical Limited

Completed

PerQseal®+ Early Feasibility Study

Percutaneous Large Hole Vascular Closure

United States
Magenta Medical Ltd.

Recruiting

Magenta Elevate™ EFS in High-Risk PCI Patients

High-risk Percutaneous Coronary Intervention

United States
Abiomed Inc.

Enrolling by invitation

Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol

High-Risk Percutaneous Coronary Intervention

United States
Vivasure Medical Limited

Recruiting

PerQseal® Clinical Study

Percutaneous Large Hole Vascular Closure

United States, Germany
Portola Pharmaceuticals

Completed

A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI (INNOVATE-PCI)

Percutaneous Coronary Intervention

United States, Austria, Canada, Germany, Poland
Icahn School of Medicine at Mount Sinai
Daiichi Sankyo, Inc.; Accumetrics, Inc.

Completed

Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition (TRIAGE)

Aspirin | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy | Clopidogrel

United States
Vivasure Medical Limited

Completed

PerQseal® Impella Early Feasibility Study

Percutaneous Large Hole Vascular Closure

United States
Sanofi

Completed

The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention (SEPIA-PCI)

Angioplasty, Transluminal, Percutaneous Coronary

United States, Spain, Belgium, Canada, South Africa, Netherlands, Germany, France, Czech Republic, Slovakia
CathWorks Ltd.
Cardiovascular Research Foundation, New York

Recruiting

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment (ALL-RISE)

Percutaneous Coronary Intervention

United States, Israel
Abbott Medical Devices
Thoratec Corporation

Completed

Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study (RESIST)

Left Ventricular Assist Device | Percutaneous Lead Management

United States
State University of New York at Buffalo

Recruiting

PUSH-IT Continuing Enteral Feeds for Tracheostomy

Critical Illness | Nutritional Deficiency | Tracheostomy Complication

United States
Yale University

Enrolling by invitation

Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women (FiRST)

Coronary Disease | Percutaneous Coronary Intervention | Cardiac Catheterization | Myocardial Perfusion Imaging | Exercise Test

United States
Boston Scientific Corporation

Recruiting

VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS) (VITALYST EFS)

Heart Disease, Coronary | High-risk Percutaneous Coronary Intervention

United States, Sweden
St. Francis Hospital, New York

Unknown

Plavix, Prasugrel and Drug Eluting Stents Pilot Trial (PPD)

Coronary Artery Disease | Platelet Aggregation Inhibitors | PCI- Percutaneous Coronary Intervention

United States
Abbott Medical Devices
Icahn School of Medicine at Mount Sinai

Completed

Patient Centered Machine Learning Model for Bleeding and Ischemic Risk (xDAPT)

Coronary Artery Disease | Percutaneous Coronary Intervention

United States
RWTH Aachen University
Department of Biomedical Engineering, Technion, Haifa, Israel

Completed

Analysis of Myocardial Layer Specific Systolic and Diastolic Function During and After PCI (PCI-Strain)

Myocardial Ischemia | Percutaneous Coronary Intervention | Anginal Pain

Germany
Heinrich-Heine University, Duesseldorf
Abiomed Inc.; Profil Clinical Trials Coordination GmbH

Recruiting

Protect Kidney Trial

High-risk Percutaneous Coronary Intervention | Induced Acute Kidney Injury

Germany
Northwell Health

Completed

Parental Perception of COVID-19 Vaccine in Technology Dependent Patients

Mechanical Ventilation Complication | Chronic Respiratory Failure | Tracheostomy Complication

United States
Northwell Health

Recruiting

Airway Microbiome Changes After Artificial Airway Exchange in Critically-ill Pediatric Patients.

Tracheostomy | Microbial Colonization | Ventilator Associated Pneumonia | Endotracheal Tube | Pediatrics | Pediatric Infectious Disease | Tracheitis

United States
Population Health Research Institute

Completed

A Trial of Routine Aspiration Thrombectomy With Percutaneous Coronary Intervention (PCI) Versus PCI Alone in Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary PCI (TOTAL)

ST Elevation Myocardial Infarction | Acute Coronary Syndrome | Percutaneous Coronary Intervention

Canada, United States, Korea, Republic of, United Kingdom, Spain, New Zealand, France, Greece, Austria, Netherlands, Germany, Finland, Serbia, Czech Republic, Australia, Hungary, Brazil, Belgium, China, Macedonia, The Former Yugoslav...
Boehringer Ingelheim

Completed

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Atrial Fibrillation | Percutaneous Coronary Intervention

Canada, United States, Spain, Korea, Republic of, Australia, Germany, Taiwan, Hong Kong, Thailand, United Kingdom, Turkey, Netherlands, Ireland, Hungary, Croatia, Colombia, Israel, Singapore, Italy, New Zealand, Greece, Mexico, Norway, Swed... and more
Cordis Corporation

Completed

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary | Peripheral Arteriosclerosis

United States
Janssen Scientific Affairs, LLC
Bayer

Completed

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention (PIONEER AF-PCI)

Atrial Fibrillation | Percutaneous Coronary Intervention

United States, France, Poland, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Argentina, Mexico, Bulgaria, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic of, Australia, Canada, Netherlands, Denmark and more
Cogentus Pharmaceuticals

Terminated

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) (COGENT-1)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention

United States, France, Canada, Australia, Poland, Germany, Italy, Mexico, Romania, Slovakia, Hungary, Czech Republic, Chile, Bulgaria, Puerto Rico, Ukraine

Clinical Trials on Percutaneous Tracheostomy in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations